Work

Assessing safety of extractables from materials and leachables in pharmaceuticals and biologics – Current challenges and approaches

Year: 2016

Type: article

Source: Regulatory Toxicology and Pharmacology

DOI: 10.1016/j.yrtph.2016.08.011

Authors: Thomas H. Broschard, Susanne Glowienke, Uma S. Bruen, Lee M. Nagao, Andrew Teasdale, Cheryl L.M. Stults, Kim L. Li, Laurie A. Iciek, Greg Erexson, Elizabeth A. Martin, Douglas J. Ball

Institutions: Merck KGaA, Darmstadt (Germany), Novartis (Switzerland), Merck & Co., Inc., Rahway, NJ, USA (United States), AstraZeneca (United Kingdom), Amgen (United States), AbbVie (United States), Pfizer (United States)

Language: English

Topic: Analytical Methods in Pharmaceuticals

Subfield: Analytical Chemistry

Field: Chemistry

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2512138876

FWCI: 4.212

Cites: 40

Cited by: 71

Related to: 10